68Ga/18F-CAIX-LT-BCH

N/A

Report date: 2026/05/18 20:02:07
NME

Base Information

Drug Name68Ga/18F-CAIX-LT-BCH
Drug Alias Name68Ga/18F-CAIX-LT-BCH
ClassificationRadiation-emitting products > Nuclides > Gallium > 68GaRadiation-emitting products > Nuclides > Fluorine > 18FSmall molecules > Heterocyclic drugs +[4
Mechanisms of ActionPositron-emission tomography enhancers
TargetsUpdating
Therapy Area/IndicationsCarcinoma, Renal Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesBeijing Cancer Hospital
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Cancer Hospital
Inactive CompaniesN/A
Active IndicationsCarcinoma, Renal Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A